NCT04722601 2024-05-16A Dose-Finding and Efficacy Study of Venetoclax, CC-486, and Obinutuzumab in Follicular LymphomaUniversity of ChicagoPhase 1/2 Terminated2 enrolled 7 charts
NCT05107856 2024-01-31PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell MalignanciesPrelude TherapeuticsPhase 1 Terminated21 enrolled
NCT01121757 2016-09-12Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone LymphomaDuke UniversityPhase 2 Terminated11 enrolled 12 charts